Convergent Dental Inc., a privately held dental device company, announced it secured $9 million in a funding round led by existing investors Long River Ventures and the Gund Foundation, as well as new individual investors and family offices. Convergent produces Solea, an FDA-approved CO2 9.3 micron dental laser for hard and soft tissue.
The company said the latest round of funding enables continued investments in product innovation, sales, and implementation.
“We are pleased to see Solea accomplish so much in just its first year on the market,” said Will Cowen, a general partner at Long River Ventures. “Solea delivers a much improved patient experience and at the same time a compelling ROI for the dentist. It’s a clear win-win. We are happy to offer continued support to such a game-changing company.”
Convergent said Solea sales nearly doubled in Q4 2014.
“This latest round of funding will fuel Solea’s already impressive growth,” said Convergent Dental CEO Michael Cataldo. “As more dentists implement this unique technology, it is becoming obvious that we are literally changing what it means to go to the dentist. The dental laser’s impact on patients’ experiences and dental practices’ bottom line is all positive and positions Convergent Dental for even greater growth in 2015.”
Convergent Dental, Inc., is based in Natick, Mass. For more information visit www.convergentdental.com.
